2-Pathalimido-5-amino pheol

Modify Date: 2024-04-03 12:31:39

2-Pathalimido-5-amino pheol Structure
2-Pathalimido-5-amino pheol structure
Common Name 2-Pathalimido-5-amino pheol
CAS Number 117346-08-4 Molecular Weight 254.241
Density 1.5±0.1 g/cm3 Boiling Point 518.1±60.0 °C at 760 mmHg
Molecular Formula C14H10N2O3 Melting Point N/A
MSDS N/A Flash Point 267.1±32.9 °C

 Names

Name 2-(4-amino-2-hydroxyphenyl)isoindole-1,3-dione
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.5±0.1 g/cm3
Boiling Point 518.1±60.0 °C at 760 mmHg
Molecular Formula C14H10N2O3
Molecular Weight 254.241
Flash Point 267.1±32.9 °C
Exact Mass 254.069138
PSA 83.63000
LogP 0.52
Vapour Pressure 0.0±1.4 mmHg at 25°C
Index of Refraction 1.750

 MSDS

Name: N-(2-Hydroxy-4-aminophenyl)-phthalimide // Agfa Germany special Material Safety Data Sheet
Synonym:
CAS: 117346-08-4
Section 1 - Chemical Product MSDS Name:N-(2-Hydroxy-4-aminophenyl)-phthalimide // Agfa Germany special Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
117346-08-4 N-(2-Hydroxy-4-aminophenyl)-phthalimid unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 117346-08-4: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: grey
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 225 deg C
Autoignition Temperature: < 470 deg C (< 878.00 deg F)
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Negligible.
Specific Gravity/Density:
Molecular Formula: C14H10N2O3
Molecular Weight: 254.0816

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Not available.
Incompatibilities with Other Materials:
Not available.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 117346-08-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N-(2-Hydroxy-4-aminophenyl)-phthalimide - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 22 Do not breathe dust.
S 24/25 Avoid contact with skin and eyes.
S 36 Wear suitable protective clothing.
WGK (Water Danger/Protection)
CAS# 117346-08-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 117346-08-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 117346-08-4 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Synonyms

2-(4-Amino-2-hydroxyphenyl)-1H-isoindole-1,3(2H)-dione
2-Pathalimido-5-amino pheol
5-amino-2-phthalimidophenol
2-Phthalimido-5-aminophenol
2-Phthalimido-5-Amino Phenol
2-(4-amino-2-hydroxyphenyl)isoindoline-1,3-dione
1H-Isoindole-1,3(2H)-dione, 2-(4-amino-2-hydroxyphenyl)-
1H-Isoindole-1,3(2H)-dione,2-(4-amino-2-hydroxyphenyl)
Top Suppliers:I want be here

Get all suppliers and price by the below link:

2-Pathalimido-5-amino pheol suppliers

2-Pathalimido-5-amino pheol price

Related Compounds: More...
2-(5-amino-2-chloro-4-fluorophenyl)sulfanyl-N,N-dimethylbutanamide
103087-84-9
2-(5-amino-2-bromo-4-methyl-benzyl)-benzoic acid
858847-97-9
2-(5-amino-2,4,8,9-tetrazabicyclo[4.3.0]nona-1,3,5,7-tetraen-9-yl)-5-(chloromethyl)oxolane-3,4-diol
53458-47-2
2-(5-amino-2,4,7,8,9-pentazabicyclo[4.3.0]nona-1,3,5,7-tetraen-9-yl)-5-(chloromethyl)oxolane-3,4-diol
53458-33-6
2-(5-amino-1,3,4-thiadiazol-2-yl)-N-methylbenzenesulfonamide
84597-71-7
2-(5-amino-2,4,7,8,9-pentazabicyclo[4.3.0]nona-1,3,5,7-tetraen-9-yl)-5-(methylsulfonylmethyl)oxolane-3,4-diol
53458-36-9
2-[5-amino-7-(5,6-diphenyl-1,2,4-triazin-3-yl)-2,4,9-triazabicyclo[4.3.0]nona-1,3,5,7-tetraen-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
55470-36-5
2-(5-amino-6-chloropyrimidin-4-yl)sulfanylacetonitrile
19144-84-4
2-(5-amino-1,3-dihydroisoindol-2-yl)acetamide
1623-38-7
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
3-(4-Fluorophenyl)-3-methoxyazetidine hydrochloride
2286232-63-9
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
tert-Butyl-DL-alanine
1375289-11-4
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
849349-65-1